Target intelligence / Profile preview

Serum and plasma proteins at the SWCNT–protein corona interface (SWCNT-PC)

Target
SWCNT-PC
Molecular classification
Protein-nanomaterial complex, Other
01

Overview

The serum and plasma proteins at the SWCNT–protein corona interface refer to the dynamic layer of biomolecules that adsorb onto the surface of single-walled carbon nanotubes (SWCNTs) when they encounter biological fluids like blood (Monopoli et al., 2012, Nature Nanotechnology). This interface, known as the 'protein corona,' defines the biological identity of the nanoparticle, dictating its interactions with cells, its biodistribution, and its potential toxicity (Walkey & Chan, 2012, Chemical Society Reviews). Common proteins involved in this interface include albumin, fibrinogen, and various apolipoproteins, which can either facilitate cellular uptake or mark the nanotubes for clearance by the mononuclear phagocyte system (Ge et al., 2011, PNAS). While the corona itself is not a traditional therapeutic target, it is a critical factor in the development of nanomedicines, as it can interfere with the binding of surface-conjugated ligands to their intended receptors. Furthermore, the adsorption process can lead to protein denaturation or the exposure of cryptic epitopes, potentially triggering inflammatory or immune responses (Lundqvist et al., 2008, Nature Nanotechnology). Understanding and controlling this interface is essential for ensuring the safety and efficacy of SWCNT-based diagnostic and therapeutic agents. The composition of the corona is highly dependent on the SWCNT's surface chemistry, size, and the specific biological environment, making it a major factor in nanotoxicology. Research into this interface aims to predict and manipulate the corona to improve the targeting and biocompatibility of carbon-based nanomaterials.

Other names
Single-walled carbon nanotube protein coronaSWCNT-protein adsorption layerNanoparticle-protein corona
02

Biological functions

OpsonizationCellular uptakeBiodistributionImmune responseOther
03

Disease associations

InflammationOther
04

Safety considerations

ImmunogenicityProtein denaturationAltered pharmacokineticsNanotoxicity

Beyond the preview

Go deeper on Serum and plasma proteins at the SWCNT–protein corona interface (SWCNT-PC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum and plasma proteins at the SWCNT–protein corona interface (SWCNT-PC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call